Florida Medication Assisted Treatment (MAT)
Our Florida Medication Assisted Treatment (MAT) program is designed for adult patients who want to get off the merry-go-round of Florida addiction treatment and life-threatening relapse. In fact, it’s one the best therapeutic therapies for those addicted to opioids whose goal is to achieve long-term sobriety. With the assistance of evidence-based medication, our clients can achieve positive outcomes and normalize their lives. Most importantly, MAT programs like Suboxone maintenance have become the most effective and life-changing forms of addiction care in decades. MAT integration can help patients overcome the craving to use heroin and other opioids. Today, the primary medications used in most MAT programs include: Suboxone, Subutex, Sublocade, Naltrexone and Vivitrol.
Designed specifically for the treatment of alcohol and opioid addiction, medication assisted treatment (MAT) includes both specific medications and behavioral therapies that are intended to:
- Get clients focused on their recovery without cravings or withdrawal.
- Aid clients in integrating strategies and skills.
- Normalize life.
- Reduce the risk of relapse.
Get on the "Path" to Recovery
A treatment and recovery program tailored to you. Get the help you need today!
Are Subutex and Suboxone the Same?
Buprenorphine (Subutex) was developed for use as a detox aid from opioid/opiate drugs. On the other hand, Suboxone is widely used for both detox and MAT maintenance programs. Since Buprenorphine is the active ingredient in both medications, it is an easy transition from Subutex to Suboxone for patients directed under a doctor's care. While Buprenorphine was found to be effective in the treatment of opioid addiction, a propensity to "use" still remained. Many addicts tried to inject the drug intravenously in order to attain the same high as with heroin or prescription painkillers. They often succeeded, prompting development of another medication so that this could not happen. For this reason, Suboxone was designed to contain Naloxone, which blocks the effects of opioids.
The most important benefit of Suboxone and Subutex is that these medications stop the withdrawal symptoms which lead addicted people to seek more opioids. In fact, a patient on Buprenorphine is not in withdrawal, not “high”, not craving and not seeking. Subsequently, clients can begin to return to a normal life.
Sublocade - A Once-a-Month Injection
Sublocade is a once-monthly injection containing Buprenorphine. Unlike Suboxone, Sublocade contains only Buprenorphine, and not Naloxone. In this way, patients can get steady, continuous levels of Buprenorphine throughout the month without the possibility for abuse. The medication is injected as a liquid, but changes to a solid form that delivers the medication all throughout the month. This new MAT medication can only be administered by a healthcare provider. It is not available as a retail prescription. Our doctor can discuss if Sublocade is right for you after performing an assessment and consultation.
What is Vivitrol?
Vivitrol was approved by the FDA in 2010 for use in opioid addiction treatment programs. Vivitrol contains Naltrexone, which suppresses cravings. As a result, it has helped a countless number of addicts remain in recovery by preventing relapse. Vivitrol is administered monthly as an injection in a medical office. Like Suboxone, it has a proven track record of helping patient’s recover when performed as Medication Assisted Treatment (MAT), which includes behavioral therapy.
Florida Suboxone Treatment in Pompano Beach
Most people cannot stop taking opioids suddenly. They need help to change their thinking, behavior, and situation. Unfortunately, stopping abruptly has a poor success rate – fewer than 25% of patients can remain sober for even one year. This is where MAT options like Suboxone treatment can promote client sobriety, while reducing the side effects of withdrawal and cravings that typically lead to relapse.
When a doctor starts an opioid-addicted patient on Suboxone treatment, the client must be undergoing mild to moderate withdrawal. At this point, the opioids have started to exit the brain’s opioid receptors. Buprenorphine attaches and sticks to them. When this happens, the patient’s withdrawal indications improve as the receptors accept the Buprenorphine. The Suboxone then starts to overpower withdrawal symptoms and cravings. With daily Suboxone maintenance, Suboxone continues to keep the brain’s opioid receptors engaged. In fact, should the patient use another opioid at this point, the euphoric effects of that opioid will be greatly decreased or null.